HIV ANTIRETROVIRAL THERAPY
Tracking # 20-1048816
$99999.00
There are no ratings for this course
Learn moreCourse overview
A TYPICAL INITIAL HIV REGIMEN INCLUDES 3 HIV MEDICATIONS FROM A MINIMUM OF 2 DRUG CLASSES. ALTHOUGH THIS TREATMENT IS NOT CURATIVE, IT CAN PROVIDE LONGER LIVES FOR PATIENTS AND REDUCE HIV TRANSMISSION. THIS REDUCTION OF TRANSMISSION HAS BECOME A POPULAR USE OF ANTIRETROVIRAL THERAPY FOR HIV-POSITIVE INDIVIDUALS WITH AN HIV-NEGATIVE PARTNER. THE SUCCESSES OF ANTIRETROVIRAL THERAPY HAVE REDUCED HIV TO A CHRONIC CONDITION IN MANY PARTS OF THE WORLD AS PROGRESSION TO AIDS HAS BECOME RARE. STUDIES HAVE FOUND THAT THE 3-DRUG REGIMEN HAS LED TO A 60% TO 80% DECLINE IN RATES OF AIDS, HOSPITALIZATION, AND DEATH. BY 2030 THE CDC PLANS TO IMPLEMENT A 90-90-90 PLAN (90% HIV DIAGNOSED, 90% ON THERAPY, AND 90% SUPPRESSED). THIS ACTIVITY DESCRIBES THE INDICATIONS, CONTRAINDICATIONS, AND USE OF HIV ANTIRETROVIRAL THERAPY AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN PROMOTING THEIR SAFETY.
Subject areas
This course counts toward the state boards and subject areas below.